(Investigative Ophthalmology and Visual Science. 1999;40:2660-2667.)
© 1999
by The Association for Research in Vision and Ophthalmology, Inc.
Inhibition of Caspase Activity in Retinal Cell Apoptosis Induced by Various Stimuli In Vitro
Gülgün Tezel and
Martin B. Wax
From the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri.
 |
Abstract
|
|---|
PURPOSE. Although recent work implicates a decisive role for a family of
cysteine aspartic acid proteases, termed caspases, as mediators of
neuronal apoptosis, little is known about caspase activation that
accompanies apoptosis in the retina. The purpose of this study was to
investigate caspase activation in retinal cell apoptosis induced by
various stimuli, including simulated ischemia, excitotoxicity, and
antibody to heat shock protein 27 (hsp27), and to assess whether the
inhibition of caspases can block apoptosis in retinal cells induced by
different stimuli.
METHODS. Apoptotic cell death induced in cultured retinal cells by simulated
ischemia, excitotoxicity, or hsp27 antibody was examined by terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling technique.
Changes in the caspase activity were studied using western blot
analysis and a fluorometric protease activity assay in the presence or
absence of caspase inhibitors. In addition, changes in the expression
of bcl-2 and bax were examined by western blot analysis.
RESULTS. The authors in vitro observations revealed that the apoptotic process
in retinal cells induced by different stimuli share a common
executioner proteolysis cascade, including caspase-3 and poly-(ADP
ribose) polymerase cleavage. One exception, however, was that caspase-8
activation was only observed during the apoptosis induced by hsp27
antibody. In retinal cells going to apoptosis regardless of the
stimulus, bcl-2 expression was decreased and bax expression was
increased. Furthermore, the authors observed that treatment of retinal
cells with inhibitors of caspases, including B-D-FMK and Z-IETD-FMK,
blocked the apoptotic cell death induced by different stimuli.
CONCLUSIONS. The authors observations provide a better understanding of the
apoptotic process in retinal cells at molecular level and demonstrate
an effective blockade of caspase activation with specific inhibitors.
These findings may have therapeutic implications in the treatment of
neuroretinal diseases, which are characterized by apoptotic cell
death.
 |
Introduction
|
|---|
Apoptotic cell death represents ordered biochemical events, which
are initiated in response to disparate stimuli and proceed differently
in diverse cell types. Apoptosis has been implicated in the death of
retinal cells during both retinal differentiation and
degeneration.1
2
In several diseases such as glaucoma,
age-related macular degeneration, and diabetic retinopathy, which
comprise the leading causes of blindness worldwide,3
4
5
6
7
retinal cell death is thought to be preceded by an apoptotic mechanism.
In addition, photoreceptor degeneration in animal models of retinitis
pigmentosa occurs through apoptosis.8
9
10
Although recent
work implicates a decisive role for a family of cysteine aspartic acid
proteases, termed caspases, as mediators of neuronal apoptosis, little
is known about the caspase activation that mediates apoptotic retinal
cell death. For example, upregulation of a CPP32-like protease was
observed in the retina after optic nerve transsection, and this was
shown to be prevented by caspase inhibitor treatment11
;
however, the relevance of an axotomy model to clinical disease is
limited.
We therefore sought to study caspase activation in retinal cells in
response to various stimuli that are thought to be relevant to numerous
neuroretinal disorders. In glaucomatous optic neuropathy, for example,
retinal ganglion cell apoptosis has been identified in experimental
glaucoma models12
13
and postmortem studies of human eyes
with glaucoma.14
15
Multiple causative factors thought to
be associated with glaucomatous optic neuropathy, which might initiate
apoptotic cell death, include chronic retinal ischemia16
and excitotoxicity.17
18
There also is considerable
evidence which suggests that an aberrant autoimmunity may contribute to
optic neuropathy in glaucoma,19
20
and some patients with
glaucoma have elevated titers of serum antibodies to heat shock
proteins.21
Furthermore, antibodies against small heat
shock proteins, such as heat shock protein 27 (hsp27), can trigger cell
death in retinal cells, in vitro and ex vivo, through an apoptotic
mechanism.22
We studied the apoptotic signaling cascade in cultured retinal cells
exposed to several apoptotic stimuli, including simulated ischemia,
excitotoxicity, and hsp27 antibody. The function of these stimuli in
the apoptotic process was examined by studying the activation of
caspases and alterations in the bcl-2 family of proteins in cultured
retinal cells. Here, we present in vitro evidence that the apoptotic
process in retinal cells induced by different stimuli share a common
mechanism involving caspase-3 and poly-(ADP ribose) polymerase (PARP)
cleavage, but differ in their ability to activate caspase-8, which only
occurred during apoptosis induced by hsp27 antibody. Furthermore,
treatment with caspase inhibitors effectively blocks the apoptotic
process in retinal cells exposed to different apoptotic stimuli.
 |
Materials and Methods
|
|---|
Cell Culture
We used an immortalized rat retinal cell line (E1A.NR3) that
contains cells expressing antigens specific for photoreceptors, bipolar
cells, ganglion cells, and retinal glial cells,23
which
has been used successfully in several previous
studies.22
24
The retinal cells were maintained in
Dulbeccos modified Eagles medium supplemented with 10% fetal
bovine serum and 1% each of nonessential amino acids,
L-glutamine, vitamins, and antibiotics.23
All
tissue culture reagents were purchased from Gibco (Grand Island, NY).
Experimental Design
The retinal cells were plated either on
75-cm2 cell culture flasks (Costar, Cambridge,
MA) at a density of 20 x 104 cells/flask at
a final volume of 12 ml or on 6-well plates (Costar) at a density of
3 x 104 cells/well at a final volume of 2
ml/well. Cells grown to approximate confluence then were incubated in
different conditions for 24 hours. For simulated ischemia, cells were
exposed to reduced oxygen tensions in medium lacking glucose. Hypoxia
was maintained by placing the cultures in an airtight perfusion chamber
with a controlled flow of 95% N2/5%
CO2. To examine the effects of excitotoxins,
cells were incubated in the presence of glutamate receptor agonists,
including N-methyl-D-aspartate (NMDA, 100 µM)
and a non-NMDA subtype,
-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA, 100
µM) (Sigma, St. Louis, MO). To examine the effects of antibody to
hsp27, cells were similarly incubated in the presence of monoclonal
antibody against hsp27 (100 µg/ml; Stress Gen, Victoria, BC, Canada).
These are optimum conditions to induce apoptosis in E1A.NR3 cell line,
based on previous concentration-response experiments.22
To examine the caspase cascade, retinal cells also were incubated under
several stress conditions in the presence or absence of different
concentrations of caspase inhibitors. One of the inhibitors we used,
boc-aspartyl(Ome)-fluoromethylketone (BAF, B-D-FMK; Enzyme System
Products, Livermore, CA) is a cell-permeable, nonselective inhibitor of
caspases. It has been shown to inhibit caspase-3 and PARP cleavage as
well as Fas-mediated death in a dose-dependent manner and thus prevents
neuronal death in experimental systems.25
26
27
28
29
30
In addition,
we used the caspase inhibitor
CBZ-Ile-Glu(Ome)-Thr-Asp-(Ome)-fluoromethylketone (Z-IETD-FMK; Enzyme
System Products), which is a cell-permeable, selective inhibitor of
caspase-8.31
Control cells were maintained in a medium in
the absence of drugs or antibody to hsp27 and incubated in a tissue
culture incubator with humidified atmosphere of 5%
CO2 and 95% air at 37°C.
After incubation, the cells were washed with phosphate-buffered saline
solution and labeled using terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL)
technique32
for morphologic analysis of apoptosis and
quantification of apoptotic cells. In addition, the cells were used in
western blot analysis and a protease activity assay. The experiments
described below were repeated three times for each condition.
Morphologic Analysis of Apoptosis
An in situ cell death detection kit (Boehringer Mannheim,
Mannheim, Germany) was used to identify the apoptotic cells by TUNEL
technique according to the instructions of the manufacturer. Briefly,
after fixation, permeabilization, and blocking steps, air-dried cells
were incubated with a mixture of fluorescein-labeled nucleotides and
terminal deoxynucleotidyl transferase for 1 hour. Terminal
deoxynucleotidyl transferase catalyzes the polymerization of labeled
nucleotides to free 3'-OH terminals of DNA fragments. Cells incubated
with fluorescein-labeled nucleotide mixture without the presence of
terminal deoxynucleotidyl transferase served as a negative control.
Cells previously treated with DNase I (1 mg/ml) to induce breaks in the
DNA strands served as a positive control.
For quantitative analysis of apoptosis, TUNEL-positive cells were
counted in triplicate wells under fluorescence microscope (Olympus,
Tokyo, Japan). The percentage of apoptosis was calculated using the
total number of cells in these wells determined using a Coulter counter
after trypsinization of the cells.
Western Blot Analysis
After washing the cells with phosphate-buffered saline, they were
lysed in sample buffer (1% SDS, 100 mM dithiothreitol (DTT), 60 mM
Tris, pH 6.8, 0.001% bromophenol blue). Protein concentrations were
determined using the BCA method (Sigma). The samples were boiled for 5
minutes before subjecting them to electrophoresis.
Samples (50 µg of total protein) were separated by electrophoresis in
10% to 15% sodium dodecyl sulfate polyacrylamide gels at 160 V for 1
hour and electrophoretically transferred to polyvinylidene fluoride
membranes (Millipore, Marlboro, MA) using a semi-dry transfer system
(BioRad, Hercules, CA). After transfer, membranes were blocked in a
buffer (50 mM Tris-HCl, 154 mM NaCl, 0.1% Tween-20, pH 7.5) containing
5% nonfat dry milk for 1 hour and then overnight in the same buffer
containing a dilution of primary antibody and sodium azide. Primary
antibodies were monoclonal antibodies to caspase-8 or PARP or
polyclonal antibodies to caspase-3, bcl-2, or bax (Pharmingen, San
Diego, CA) and were used at a dilution of 1:1000. After several washes
and the second blocking for 20 minutes, the membranes were incubated
with a dilution of secondary antibodies conjugated with horseradish
peroxidase (Fisher Scientific, Pittsburgh, PA) at 1:2000 for 1 hour.
Immunoreactive bands were visualized by enhanced chemiluminescence
using commercial reagents (Amersham Life Science, Arlington Heights,
IL).
In Vitro Caspase-3 Assay
Caspase-3like (YAMA/CPP32) protease activity was measured in a
fluorometric assay by measuring the extent of cleavage of the
fluorometric peptide substrate as previously
described.30
33
Briefly, the cells were washed with
phosphate-buffered saline and lysed in buffer A (10 mM Hepes, pH 7.4,
42 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.5% CHAPS, 1
mM PMSF, and 1 µg/ml leupeptin). Lysate was then combined in a
96-well plate with buffer B (25 mM Hepes, pH 7.5, 1 mM EDTA, 3 mM DTT,
0.1% CHAPS, and 10% sucrose) containing
Ac-Asp-Glu-Val-Asp-7-amino-4-trifluoro-methyl coumarin (Ac-DEVD-AMC)
fluorometric substrate (50 µM). Positive controls included purified
recombinant caspase-3 (0.1 µg; Upstate Biotechnology, Lake Placid,
NY). Fluorescence was measured at an excitation wavelength of 360 nm
and an emission wavelength of 460 nm in a fluorescent plate reader at
different time points up to 180 minutes. The protease activity was
expressed as picomoles of substrate per milligram of protein per
minute, as calculated using the linear range of the assay.
 |
Results
|
|---|
Induction and Inhibition of Retinal Cell Apoptosis
Apoptosis was induced in cultured retinal cells after incubation
in the presence of simulated ischemia, excitotoxins, or hsp27 antibody
for 24 hours. Although control cells incubated under normal condition
retained normal morphology, retinal cells incubated under different
stress conditions exhibited specific morphologic changes of apoptotic
cell death, including cell body shrinkage and compaction of the
nucleus. In addition, apoptotic cells exhibited bright labeling of
fragmented nuclear DNA by the TUNEL technique (Fig. 1)
. Quantitative analysis of retinal cells revealed that 15% to 30% of
the cells were TUNEL-positive in cultures incubated in the presence of
different stimuli. After incubation under identical stress conditions
in the presence of the caspase inhibitor, B-D-FMK (50 µM), the
apoptosis rate decreased to 4% to 5% of the cell population, which
was similar to the apoptosis rate in control cells (3% to 4%) (Fig. 2)
.

View larger version (90K):
[in this window]
[in a new window]
|
Figure 1. Morphologic analysis of apoptotic cell death in retinal cells using
TUNEL technique. (A) Phase contrast microscope image of
retinal cells incubated under normal condition; (B) phase
contrast microscope image of retinal cells incubated under ischemic
condition; (C) fluorescence microscope image of control
retinal cells stained using TUNEL technique; (D)
fluorescence microscope image of retinal cells incubated under ischemic
condition and stained using TUNEL technique. Arrows show
cells exhibiting positive TUNEL. Original magnification, x40.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Figure 2. Quantitative analysis of apoptotic cell death in retinal cells using
TUNEL technique. The percentage of TUNEL-positive cells incubated under
different apoptotic stimuli (white columns) decreased to
levels similar to control after incubation in the presence of caspase
inhibitor (B-D-FMK) (50 µM) (black columns). Error
bars, SD. NMDA, N-methyl-D-aspartate; AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid.
|
|
Involvement of Caspases in Retinal Cell Apoptosis and Inhibition of
Caspase Activity by Caspase Inhibitors
To examine the role of the caspase cascade in retinal apoptosis
induced by different stimuli, lysates of retinal cells incubated in the
presence of simulated ischemia, excitotoxins, or hsp27 antibody were
used in western blot analysis. Western blot analysis demonstrated
cleavage of caspase-3 and PARP in retinal cells incubated under all the
stress conditions studied. The presence of caspase-3 activation was
assessed by the observation of the 17-kDa subunit that was derived from
the cleavage of 32-kDa pro-enzyme caspase-3. PARP was cleaved from its
116-kDa form to an 85-kDa residual fragment, characteristic of cells in
the process of apoptosis. However, among different stimuli studied,
only incubation in the presence of antibody against hsp27 caused
cleavage and hence activation of caspase-8. Western blot analysis
revealed a 55-kDa immunoreactive band corresponding to caspase-8 and
approximately 30- and 20-kDa cleaved products using the lysates of
retinal cells incubated with hsp27 antibody. No cleavage of caspase-8,
caspase-3, or PARP was detected using the extracts of the control
retinal cells maintained in a medium in the absence of drugs or
antibody to hsp27 and incubated in a tissue culture incubator with
humidified atmosphere of 5% CO2 and 95% air at
37°C (Fig. 3)
.

View larger version (41K):
[in this window]
[in a new window]
|
Figure 3. Western blot findings demonstrating caspase and PARP cleavage.
Column 1, control retinal cells; column
2, retinal cells incubated under ischemic condition;
column 3, retinal cells incubated with NMDA;
column 4, retinal cells incubated with AMPA;
column 5, retinal cells incubated with antibody against
hsp27. Fifty-fivekilodalton immunoreactive band corresponding to
caspase-8 and its 30- and 20-kDa cleaved products were observed only
using the lysates of retinal cells incubated with hsp27 antibody.
However, the cleavage of caspase-3 and PARP was observed using the
extracts of retinal cells incubated under all the stress conditions
studied, including the presence of ischemia, excitotoxins, and hsp27
antibody. The presence of caspase-3 activation was assessed by the
observation of a 17-kDa subunit that was derived from the cleavage of
32-kDa proenzyme caspase-3. PARP was cleaved from its 116-kDa form to
an 85-kDa residual fragment characteristic of cells in the process of
apoptosis. No cleavage of caspase-8, caspase-3, or PARP was detected
using the extracts of the control retinal cells.
|
|
In addition to caspases, we also examined the bcl-2 family of proteins,
which modulate caspase activation. Western blot analysis revealed the
contribution of the members of bcl-2 family to retinal cell apoptosis
induced by different stimuli, including simulated ischemia,
excitotoxins, and hsp27 antibody. In retinal cells going to apoptosis
regardless of the stimuli used to induce apoptotic cell death, bcl-2
expression was lower and bax expression was higher in comparison to
control retinal cells (Fig. 4)
.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 4. Western blot findings demonstrating alterations in the bcl-2 family of
proteins. In comparison to the control cells bcl-2 expression was lower
and bax expression was higher in retinal cells incubated under
different stress conditions that induced apoptotic cell death
(column 1, control retinal cells; column
2, retinal cells incubated under ischemic condition;
column 3, retinal cells incubated with NMDA;
column 4, retinal cells incubated with AMPA;
column 5, retinal cells incubated with antibody against
hsp27).
|
|
To examine the effect of caspase inhibitors on caspase cleavage,
retinal cells were incubated under stress conditions in the presence of
caspase inhibitors. Western blot analysis revealed that treatment with
caspase inhibitors prevented the cleavage of caspases and PARP in
retinal cells incubated under different stress conditions, including
simulated ischemia, excitotoxins, and hsp27 antibody. The nonselective
caspase inhibitor BAF (B-D-FMK) (50 µM) inhibited caspase-3 and PARP
cleavage but not prominent caspase-8 cleavage. Z-IETD-FMK (20 µM), a
selective caspase-8 inhibitor, inhibited the cleavage of caspase-8 and
only partially inhibited the cleavage of caspase-3 and PARP. This
observation suggests the presence of an additional pathway during the
apoptosis induced by hsp27 antibody, which includes caspase-8
activation (Fig. 5) .

View larger version (34K):
[in this window]
[in a new window]
|
Figure 5. Western blot findings using retinal cells treated by caspase
inhibitors. Incubation of the retinal cells under different stress
conditions in the presence of drugs inhibiting caspases prevented
specific caspase cleavage. Column 1, control retinal
cells; column 2, retinal cells incubated with antibody
against hsp27; column 3, retinal cells incubated with
antibody against hsp27 in the presence of caspase inhibitor, B-D-FMK
(50 µM); column 4, retinal cells incubated with
antibody against hsp27 in the presence of specific caspase-8 inhibitor,
Z-IETD-FMK (20 µM). While B-D-FMK inhibited caspase-3 and PARP
cleavage but not prominently caspase-8 cleavage, Z-IETD-FMK inhibited
the cleavage of caspase-8 and only partially the cleavage of caspase-3
and PARP.
|
|
We then performed fluorometric analysis using retinal cells incubated
under different stress conditions to measure the cleavage of
Ac-DEVD-AMC, which reflects caspase-3like activity. In accordance
with the results of western blot analysis, the amount of DEVD-AMC
cleaving activity was increased in retinal cells incubated under
different apoptotic stimuli (range, 11.024.8 pmol/mg protein/min)
compared to control cells (range, 34.6 pmol/mg protein/min).
Approximately 2.1 to 3.4 times increase in the DEVD-AMC cleaving
activity in retinal cells incubated in the presence of different
stimuli is shown in Figure 6
. Treatment of retinal cells with caspase inhibitors inhibited
caspase-3like activity in a concentration-dependent manner (Fig. 7)
. The caspase-3like activity in retinal cells was reduced by ~
70% with 50 µM of B-D-FMK (range, 4.37.2 pmol/mg protein/min).
However, treatment of retinal cells with 20 µM of the selective
inhibitor of caspase-8, Z-IETD-FMK, resulted in decreased
caspase-3like activity only in retinal cells incubated with hsp27
antibody (~40%). This observation suggests that hsp27
antibody-mediated retinal cell apoptosis involves caspase-8 activation
(Figs. 6
7)
.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 6. In vitro protease activity assay. Caspase-3like activity was
increased in retinal cells incubated under different stress conditions
compared to control cells (white columns) and this
increase was blocked by caspase inhibitor, B-D-FMK (50 µM)
(black columns). However, treatment with specific
caspase-8 inhibitor, Z-IETD-FMK (20 µM) (gray columns)
was only effective to decrease caspase-3like activity in retinal
cells incubated with hsp27 antibody. Error bars, SD. NMDA,
N-methyl-D-aspartate; AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7. In vitro protease activity assay. Caspase-3like activity was blocked
in retinal cells incubated with hsp27 antibody by a nonselective
caspase inhibitor, B-D-FMK (black circles) and a
specific caspase-8 inhibitor, Z-IETD-FMK (white circles)
in a concentration-dependent manner. Error bars, SD.
|
|
 |
Discussion
|
|---|
A variety of death commitment signals in mammalian cells converge
to activate the executioner proteolysis cascade that play a critical
role in initiating and sustaining the biochemical events that result in
apoptotic cell death. The proteolysis is mediated by a conserved group
of caspases that are related to mammalian interleukin 1ßconverting
enzyme and to nematode CED-3.34
35
Caspases exist as
proenzymes that are proteolytically processed to their active forms in
response to an apoptosis-inducing stimulus. Activated caspases cleave
each others precursors into mature, active enzymes in a proteolytic
cascade similar to complement activation or blood clotting. For
example, after cell-surface death receptors such as tumor necrosis
factor-
-1 or the CD95/Fas are activated, their cytoplasmic tails
bind to downstream adapter proteins, such as FADD (Fas-associated death
domain protein). The FasFADD complex then binds a
receptor-interacting protein (FLICE) that contains an interleukin
1ßconverting enzymerelated protease domain (caspase-8) and can
initiate the caspase cascade directly.36
37
38
Although this
pathway of caspase cascade eventually induces caspase-3 activation,
caspase-3 also can be activated by other upstream mediators, which are
unrelated to caspase-8. As a consequence, PARP, the major substrate of
caspase-3, is cleaved, which catalyzes the poly(ADP-ribosyl)ation of
various nuclear proteins with NAD as substrate and contributes to cell
death by depleting the cell of NAD and ATP.39
40
In
addition, caspases contribute to apoptosis through direct disassembly
of cell structures, including nuclear lamina and
cytoskeleton.41
Our in vitro observations revealed that the apoptotic machinery in
retinal cells is regulated, in part by a proteolytic cascade. Although
all the stimuli studied, including simulated ischemia, excitotoxins,
and hsp27 antibody, eventually caused the cleavage of caspase-3 and
PARP, caspase-8 was cleaved only during apoptosis induced by hsp27
antibody. This observation suggests a different upstream signaling
pathway for hsp27 antibodymediated apoptosis, despite similar
downstream effector events to those induced by other stimuli.
We also observed that treatment of retinal cells with compounds capable
of inhibiting multiple proteins in the caspase family can block the
downstream apoptosis. One of the inhibitors we used, B-D-FMK, is a
reactive derivative of aspartic acid, the amino acid locus that
caspases cleave distally. Because of its membrane permeability, it is
effective in living cells, and it has been shown to inhibit caspase-3
and PARP cleavage as well as Fas-mediated death in a dose-dependent
manner and thereby to prevent neuronal death.25
26
27
28
29
30
In
accordance with these findings, our studies revealed that B-D-FMK and
in part, Z-IETD-FMK, a specific inhibitor of caspase-8,31
can prevent the execution of apoptosis in retinal cells exposed to
different apoptotic stimuli.
A recent study of two Drosophila mutant strains that exhibit
an age-related retinal degeneration and a human homologue of retinitis
pigmentosa has revealed that cells rescued from apoptosis can serve a
useful function.42
Preservation of visual function by
blockade of apoptosis provides a strong rationale for further
exploration of antiapoptotic strategies in the treatment of retinal
degenerative diseases. As seen in glaucomatous optic neuropathy retinal
apoptosis can be triggered by a broad array of different stimuli;
therefore, caspases may be attractive targets to block apoptosis,
regardless of the causative event.
Another intracellular pathway, which modulates cell survival by
affecting adapters needed for the activation of caspases, involves
bcl-2 family members.43
44
The bcl-2 family of proteins
includes both apoptosis-promoting (e.g., bax and bad) and
apoptosis-inhibiting (e.g., bcl-2 and bcl-xL)
members.45
46
47
48
This is consistent with our observations
that during the retinal cell apoptosis induced by all three stimuli,
bcl-2 expression decreased and bax expression increased.
Previous studies of neuronal tissues have shown the contribution of the
caspases and/or bcl-2 pathway to the apoptosis induced by different
stimuli we examined in retinal cells. For example, the contribution of
the caspases in the apoptotic component of ischemia-induced neuronal
death has been demonstrated.30
49
50
51
52
53
In addition,
glutamate-induced apoptosis of cerebellar granule neurons has been
shown to be mediated by a posttranslational activation of
caspase-3.54
Moreover, bax promotes apoptotic cell death
in neuronal ischemia; bax expression is increased in neurons that die,
and the upregulation of bcl-2 expression in surviving neurons protects
these neurons from cell death.55
56
Cells respond to a variety of stress conditions, including ischemia and
excitotoxicity, by adaptive changes that either blunt the death signal
or prevent the activation of sensor or effector molecules and thereby
limit and/or repair cell damage. One of the components of these
cellular response mechanisms is the upregulation of the expression of
heat shock proteins. Heat shock proteins, including hsp27, increase
cell survival and resistance to apoptosis by affecting both upstream
signaling and downstream effector events as shown in neuronal cells as
well as in cancer cell lines.57
58
59
Considerable evidence
suggests that antibodies against heat shock proteins may confer a loss
of protective role of endogenous heat shock proteins and thereby
facilitate apoptotic cell death. For example, antibodies that bind heat
shock proteins can increase the rate of cell death after certain
noxious insults.60
In accordance with these
observations, the presence of antibodies to hsp27 recently has been
found to correlate with an improved survival in patients with breast
cancer.61
In addition to the previous observation of the
role of antibodies against small heat shock proteins to induce
apoptosis in retinal cells,22
current findings reveal the
role of caspase cascade and bcl-2 pathway in the retinal cell apoptosis
induced by hsp27 antibody.
In conclusion, our in vitro observations provide evidence that
apoptosis in retinal cells induced by simulated ischemia, excitotoxins,
or hsp27 antibody shares a common executioner proteolysis cascade,
including caspase-3 and PARP cleavage, but differ in their ability to
activate caspase-8, which occurs during apoptosis induced by hsp27
antibody. In addition, during the apoptotic process in retinal cells
expression of bcl-2 decreased and expression of bax increased
regardless of the cell stressor used to induce apoptosis. An improved
understanding the apoptotic process at molecular level can facilitate
efforts to rationally manipulate apoptosis for therapeutic gain. Our
observations of the protective role of caspase inhibitors during
retinal cell apoptosis induced by different stimuli may therefore have
some therapeutic implications in future studies. Such a treatment
modality may provide a means to rescue and protect retinal neuronal
cells from apoptotic cell death induced by multiple causes of injury
and thus be useful in the treatment of many neuroretinal diseases,
including glaucomatous optic neuropathy. Further evaluation of
caspase-independent mechanisms of cell death, as well as the function
of cells rescued by caspase inhibitors, will determine the potential of
caspase inhibitors for the treatment of retinal cell death.
 |
Acknowledgements
|
|---|
The authors thank Gail M. Seigel for providing E1A.NR3 rat retinal
cell line and Eugene M. Johnson, Jr. for his helpful advice.
 |
Footnotes
|
|---|
Supported in part by Grant EY12314 (MBW) from National Eye Institute,
Bethesda, Maryland, and an unrestricted grant to Washington University
School of Medicine, Department of Ophthalmology and Visual Sciences
from Research to Prevent Blindness Inc., New York, New York.
Submitted for publication January 22, 1999; revised June 1, 1999; accepted June 22, 1999.
Commercial relationships policy: N.
Corresponding author: Martin B. Wax, Department of Ophthalmology and
Visual Sciences, Washington University School of Medicine, Box 8096,
660 South Euclid Avenue, St. Louis, MO 63110. E-mail: wax{at}am.seer.wustl.edu
 |
References
|
|---|
-
Rosenbaum, PS, Gupta, H, Savitz, SI, Rosenbaum, DM (1997) Apoptosis in the retina Clin Neurosci 4,224-232[Medline][Order article via Infotrieve]
-
Reme, CE, Rimm, C, Hafezi, F, Marti, A, Wenzel, A. (1998) Apoptotic cell death in retinal degenerations Prog Retinal Eye Res 17,443-464[Medline][Order article via Infotrieve]
-
Rahmani, B, Tielsch, JM, Katz, J, et al (1996) The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey Ophthalmology 103,1721-1726[Medline][Order article via Infotrieve]
-
Quigley, HA (1996) Number of people with glaucoma worldwide Br J Ophthalmol 80,385-387[Free Full Text]
-
Xu, GZ, Li, WW, Tso, MO (1996) Apoptosis in human retinal degenerations Trans Am Ophthalmol Soc 94,411-430[Medline][Order article via Infotrieve]
-
Barber, AJ, Lieth, E, Khin, SA, Antonetti, DA, Buchanan, AG, Gardner, TWJ (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J Clin Invest 102,783-791[Medline][Order article via Infotrieve]
-
Starr, CE, Guyer, DR, Yannuzzi, LA (1998) Age-related macular degeneration. Can we stem this worldwide public health crisis? Postgrad Med 103,161-164
-
Wong, F. (1995) Photoreceptor apoptosis in animal models. Implications for retinitis pigmentosa research Arch Ophthalmol 113,1245-1247[Medline][Order article via Infotrieve]
-
Adler, R. (1996) Mechanisms of photoreceptor death in retinal degenerations.
From the cell biology of the 1990s to the ophthalmology of the 21st century Arch Ophthalmol 114,79-83[Abstract]
-
Li, ZY, Milam, AH (1995) Apoptosis in retinitis pigmentosa Anderson, RE LaVail, MM Hollyfield, JG eds. Degenerative Diseases of the Retina ,1-8 Plenum Press New York.
-
Kermer, P, Klocker, N, Labes, M, B
hr, M. (1998) Inhibition of CPP-32-like
proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo J Neurosci 18,4656-4662[Abstract/Free Full Text]
-
Quigley, HA, Nickells, RW, Kerrigan, LA, Pease, ME, Thibault, DJ, Zack, DJ (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis Invest Ophthalmol Vis Sci 36,774-786[Abstract/Free Full Text]
-
GarciaValenzuela, E, Shareef, S, Walsh, J, Sharma, SC (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma Exp Eye Res 61,33-44[Medline][Order article via Infotrieve]
-
Kerrigan, LA, Zack, DJ, Quigley, HA, Smith, SC, Pease, ME (1997) TUNEL-positive ganglion cells in human primary open-angle glaucoma Arch Ophthalmol 115,1031-1035[Abstract]
-
Wax, MB, Tezel, G, Edward, DP (1998) Clinical and histopathological findings of a patient with normal pressure glaucoma Arch Ophthalmol 116,993-1001[Abstract/Free Full Text]
-
Hitchings, RA, Spaeth, GL (1977) Fluorescein angiography in chronic simple and low-tension glaucoma Br J Ophthalmol 61,126-132[Abstract/Free Full Text]
-
Dreyer, EB, Zurakowski, D, Schumer, RA, Podos, SM, Lipton, SA (1996) Elevated glutamate in the vitreous body of humans and monkeys with glaucoma Arch Ophthalmol 114,299-305[Abstract]
-
Chaudhary, P, Ahmed, F, Sharma, SC (1998) MK801a neuroprotectant in rat hypertensive eyes Brain Res 792,154-158[Medline][Order article via Infotrieve]
-
Cartwright, MJ, Grajewski, AL, Friedberg, ML, Anderson, DR, Richards, DW (1992) Immune-related disease and normal-tension glaucoma Arch Ophthalmol 110,500-502[Abstract]
-
Wax, MB, Barrett, DA, Pestronk, A. (1994) Increased incidence of paraproteinemia and autoantibodies in patients with normal pressure glaucoma Am J Ophthalmol 117,561-568[Medline][Order article via Infotrieve]
-
Wax, MB, Tezel, G, Sato, I, et al (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal pressure glaucoma Am J Ophthalmol 125,145-157[Medline][Order article via Infotrieve]
-
Tezel, G, Seigel, GM, Wax, MB (1998) Autoantibodies to small heat shock proteins in glaucoma Invest Ophthalmol Vis Sci 39,2777-2787
-
Seigel, GM (1996) Establishment of an E1A-immortalized retinal cell culture In vitro Cell Dev Biol 32,66-68
-
Adamus, G, Machnicki, M, Seigel, GM (1997) Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy Invest Ophthalmol Vis Sci 38,283-291[Abstract/Free Full Text]
-
Graybill, TL, Dolle, RE, Helaszek, CT, Miller, RE, Ator, MA (1994) Preparation and evaluation of peptidic aspartyl hemiacetals as reversible inhibitors of interleukin-1 ß converting enzyme (ICE) Int J Pept Protein Res 44,173-182[Medline][Order article via Infotrieve]
-
Mashima, T, Naito, M, Kataoka, S, Kawai, H, Tsuruo, T. (1995) Aspartate-based inhibitor of interleukin-1 ß-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells Biochem Biophys Res Commun 209,907-915[Medline][Order article via Infotrieve]
-
Milligan, CE, Prevette, D, Yaginuma, H, et al (1995) Peptide inhibitors of the ICE protease family arrest programmed cell death of motor neurons in vivo and in vitro Neuron 15,385-393[Medline][Order article via Infotrieve]
-
Nicholson, DW, Ali, A, Thornberry, NA, et al (1995) Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis Nature 376,37-43[Medline][Order article via Infotrieve]
-
Enari, M, Talanian, RV, Wong, WW, Nagata, S. (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis Nature 380,723-726[Medline][Order article via Infotrieve]
-
Cheng, Y, Deshmukh, M, DCosta, A, et al (1998) Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury J Clin Invest 101,1992-1999[Medline][Order article via Infotrieve]
-
Martin, DA, Siegel, RM, Zheng, L, Lenardo, MJ (1998) Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACH
1) death signal J Biol Chem 273,4345-4349[Abstract/Free Full Text]
-
Gavrieli, Y, Sherman, Y, BenSasson, SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 119,493-501[Abstract/Free Full Text]
-
Bump, NJ, Hackett, M, Hugunin, M, et al (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35 Science 269,1885-1888[Abstract/Free Full Text]
-
Yuan, J, Shaham, L, Ledoux, S, Ellis, HM, Horvitz, HR. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to
mammalian interleukin-1ß-converting enzyme Cell 75,641-652[Medline][Order article via Infotrieve]
-
Lazebnik, YA, Kaufmann, SH, Desnoyers, S, Poirier, GC, Earnshaw, WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE Nature 371,346-347[Medline][Order article via Infotrieve]
-
Hsu, H, Xiong, J, Goeddel, DV (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation Cell 81,495-504[Medline][Order article via Infotrieve]
-
Stanger, BZ, Leder, P, Lee, TH, Kim, E, Seed, B. (1995) RIP. A novel protein containing a death domain that interacts with FAS/APO-1 (CD95) in yeast
and causes cell death Cell 81,513-523[Medline][Order article via Infotrieve]
-
Muzio, M, Chinnaiyan, AM, Kischkel, FC, et al (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85,817-827[Medline][Order article via Infotrieve]
-
Tewari, M, Quan, LT, ORourke, K, et al (1995) Yama/CPP32ß, a mammalian homolog of CED-3 is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase Cell 81,801-809[Medline][Order article via Infotrieve]
-
CasciolaRosen, L, Nicholson, DW, Chong, T, et al (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death J Exp Med 183,1957-1964[Abstract/Free Full Text]
-
Thornberry, NA, Lazebnik, Y. (1998) Caspases: enemies within Science 281,1312-1322[Abstract/Free Full Text]
-
Davidson, FF, Steller, H. (1998) Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants Nature 391,587-591[Medline][Order article via Infotrieve]
-
Liu, X, Kim, CN, Yang, J, Jemmerson, R, Wang, X. (1996) Induction of apoptotic program in cell-free extract: requirements for DATP and cytochrome c Cell 86,147-157[Medline][Order article via Infotrieve]
-
Zou, H, Henzel, WJ, Liu, X, Lutschg, A, Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome
c-dependent activation of caspase-3 Cell 90,405-413[Medline][Order article via Infotrieve]
-
Vaux, DL, Cory, S, Adams, JM (1988) Bcl-2 gene promotes haemopoeitic cell survival and cooperates with c-myc to immortalize pre-ß cells Nature 335,440-442[Medline][Order article via Infotrieve]
-
Monney, L, Otter, I, Olivier, R, et al (1996) Bcl-2 over expression blocks activation of the death protease CPP32/Yama/Apopain Biochem Biophys Res Commun 221,340-345[Medline][Order article via Infotrieve]
-
Yang, J, Liu, X, Bhalla, K, et al (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked Science 275,1129-1132[Abstract/Free Full Text]
-
Kluck, RM, BossyWetzel, E, Green, DR, Newmeyer, DD (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis Science 275,1132-1136[Abstract/Free Full Text]
-
Loddick, SA, MacKenzie, A, Rothwell, NJ (1996) An ICE inhibitor z-VAD-DCB attenuates ischaemic brain damage in the rat Neuroreport 7,1465-1468[Medline][Order article via Infotrieve]
-
Gottron, FJ, Ying, HS, Choi, DW (1997) Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death Mol Cell Neurosci 9,159-169[Medline][Order article via Infotrieve]
-
Namura, S, Zhu, J, Fink, K, et al (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia J Neurosci 18,3659-3668[Abstract/Free Full Text]
-
Chen, J, Nagayama, T, Jin, K, et al (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia J Neurosci 18,4914-4928[Abstract/Free Full Text]
-
Endres, M, Wang, Z, Namura, S, Waeber, C, Moskowitz, MA (1997) Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase J Cereb Blood Flow Metab. 17,1143-1151[Medline][Order article via Infotrieve]
-
Du, Y, Bales, KR, Dodel, RC, et al (1997) Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons Proc Natl Acad Sci USA 94,11657-11662[Abstract/Free Full Text]
-
Martinou, JC, DuboisDauphin, M, Staple, JK, et al (1994) Over expression of bcl-2 in transgenic mice protects neurons from naturally occuring cell death and experimental ischemia Neuron 13,1017-1030[Medline][Order article via Infotrieve]
-
Isenmann, S, Stoll, G, Schroeter, M, Krajewski, S, Reed, JC, Bahr, M. (1998) Differential regulation of bax, bcl-2 and bcl-x proteins in focal cortical ischemia in the rat Brain Pathol 8,49-63[Medline][Order article via Infotrieve]
-
Kato, H, Kogure, K, Liu, XH, Araki, T, Kato, K, Itoyama, Y. (1995) Immunohistochemical localization of the low molecular weight stress protein HSP27 following focal cerebral ischemia in the rat Brain Res 679,1-7[Medline][Order article via Infotrieve]
-
Mehlen, P, SchulzeOsthoff, K, Arrigo, A. (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks fas/apo-1- and
staurosporine-induced cell death J Biol Chem 271,16510-16514[Abstract/Free Full Text]
-
Caprioli, J, Kitano, S, Morgan, JE (1996) Hypertermia and hypoxia increases tolerance of retinal ganglion cells to anoxia and excitotoxicity Invest Ophthalmol Vis Sci 37,2376-2381[Abstract/Free Full Text]
-
Riabowol, K, Mizzen, L, Welch, W. (1988) Heat shock is lethal to fibroblasts microinjected with antibodies against hsp70 Science 242,433-436[Abstract/Free Full Text]
-
Conroy, SE, Sasieni, PD, Amin, V, et al (1998) Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer Br J Cancer 77,1875-1879[Medline][Order article via Infotrieve]
This article has been cited by other articles:

|
 |

|
 |
 
F. Kiagiadaki and K. Thermos
Effect of Intravitreal Administration of Somatostatin and sst2 Analogs on AMPA-Induced Neurotoxicity in Rat Retina
Invest. Ophthalmol. Vis. Sci.,
July 1, 2008;
49(7):
3080 - 3089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Huang, J. B. Fileta, T. Filippopoulos, A. Ray, A. Dobberfuhl, and C. L. Grosskreutz
Hsp27 Phosphorylation in Experimental Glaucoma
Invest. Ophthalmol. Vis. Sci.,
September 1, 2007;
48(9):
4129 - 4135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. H. Grus, S. C. Joachim, K. Bruns, K. J. Lackner, N. Pfeiffer, and M. B. Wax
Serum Autoantibodies to {alpha}-Fodrin Are Present in Glaucoma Patients from Germany and the United States.
Invest. Ophthalmol. Vis. Sci.,
March 1, 2006;
47(3):
968 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Kniep, C. Roehlecke, N. Ozkucur, A. Steinberg, F. Reber, L. Knels, and R. H. W. Funk
Inhibition of Apoptosis and Reduction of Intracellular pH Decrease in Retinal Neural Cell Cultures by a Blocker of Carbonic Anhydrase.
Invest. Ophthalmol. Vis. Sci.,
March 1, 2006;
47(3):
1185 - 1192.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J C H Tan, F B Kalapesi, and M T Coroneo
Mechanosensitivity and the eye: cells coping with the pressure.
Br. J. Ophthalmol.,
March 1, 2006;
90(3):
383 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tezel, X. Yang, and J. Cai
Proteomic Identification of Oxidatively Modified Retinal Proteins in a Chronic Pressure-Induced Rat Model of Glaucoma
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3177 - 3187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tezel and X. Yang
Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro
Invest. Ophthalmol. Vis. Sci.,
November 1, 2004;
45(11):
4049 - 4059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, G. M. Seigel, and M. E. M. Kelly
An Investigation of the Neuroprotective Effects of Tetracycline Derivatives in Experimental Models of Retinal Cell Death
Mol. Pharmacol.,
November 1, 2004;
66(5):
1113 - 1122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tezel and M. B. Wax
Hypoxia-Inducible Factor 1{alpha} in the Glaucomatous Retina and Optic Nerve Head
Arch Ophthalmol,
September 1, 2004;
122(9):
1348 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. A. El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes
Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes
Invest. Ophthalmol. Vis. Sci.,
August 1, 2004;
45(8):
2760 - 2766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Guimaraes, M. Benchimol, G. P. Amarante-Mendes, and R. Linden
Alternative Programs of Cell Death in Developing Retinal Tissue
J. Biol. Chem.,
October 24, 2003;
278(43):
41938 - 41946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, A. Gorman, X. Zhou, C. Sandra, and E. Chen
Involvement of Caspase-3 in Photoreceptor Cell Apoptosis Induced by In Vivo Blue Light Exposure
Invest. Ophthalmol. Vis. Sci.,
October 1, 2002;
43(10):
3349 - 3354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang, D. M. Rosenbaum, A. R. Shaikh, Q. Li, P. S. Rosenbaum, D. J. Pelham, and S. Roth
Ischemic Preconditioning Attenuates Apoptotic Cell Death in the Rat Retina
Invest. Ophthalmol. Vis. Sci.,
September 1, 2002;
43(9):
3059 - 3066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Baptiste, A. T. E. Hartwick, C. A. B. Jollimore, W. H. Baldridge, B. C. Chauhan, F. Tremblay, and M. E. M. Kelly
Comparison of the Neuroprotective Effects of Adrenoceptor Drugs in Retinal Cell Culture and Intact Retina
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2666 - 2676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. McKinnon, D. M. Lehman, L. A. Kerrigan-Baumrind, C. A. Merges, M. E. Pease, D. F. Kerrigan, N. L. Ransom, N. G. Tahzib, H. A. Reitsamer, H. Levkovitch-Verbin, et al.
Caspase Activation and Amyloid Precursor Protein Cleavage in Rat Ocular Hypertension
Invest. Ophthalmol. Vis. Sci.,
April 1, 2002;
43(4):
1077 - 1087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yokoyama, T. Oshitari, H. Negishi, M. Dezawa, A. Mizota, and E. Adachi-Usami
Protection of Retinal Ganglion Cells from Ischemia-Reperfusion Injury by Electrically Applied Hsp27
Invest. Ophthalmol. Vis. Sci.,
December 1, 2001;
42(13):
3283 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|